The size of the Defibrillators Market in Europe is estimated at USD 3.35 billion in 2020 and to grow at a CAGR of 7.4% to reach USD 4.79 billion by 2025.
The key factors driving Europe Defibrillators Market growth include technological advances such as the emergence of automatic external defibrillators (AEDs) in public access locations, an increased incidence of sudden cardiac arrest, and increased awareness around the world. In Europe, many cases of heart failure are diagnosed each year, and the majority of them are deaths that are attributed to heart failure. It is one of the primary drivers of the defibrillator market growth in this region. Also, increased incidence of other lifestyle habits, such as diabetes, atherosclerosis, stroke, hypertension, other unhealthy eating habits, and lack of activity, among others, physical and smoking are the leading causes of CHF. Also, an increasing elderly population should increase the prevalence of CHF, thereby driving the European defibrillators market growth.
The increasing appeal of medical care should drive the sales of home care defibrillators, such as portable external defibrillators and automatic external defibrillators (AEDs). In Europe, it creates the opportunity for defibrillators market, and the ability of a defibrillator to diagnose early ventricular tachycardia and ventricular defibrillation should drive its demand in the future period. However, the cost-effectiveness, safety, high accessibility, and clinical value of pre-treatment for sudden cardiac arrest enhance the technological advancement of the Europe defibrillator market.
The high cost of these devices is acting as a significant restraint to the growth of the European Defibrillators Market.
Europe Defibrillators Market in which the low reimbursement scenarios for defibrillation procedures, the lack of advanced medical infrastructure, the small physician and patient awareness of various treatment devices are the considerable threats.
This research report segmented and sub-segmented the Europe Defibrillators Market into the following categories and evaluated market size and forecast for each segment until 2025.
Regionally, Europe is the second-largest in terms of market share in the Global Defibrillators Market. The UK is the leading market in this region. It captures 25% of the Europe Defibrillators Market.
Some of the Prominent Companies leading the Europe Defibrillators Market Profiled in the Report are Medtronic PLC (Ireland), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), LivaNova PLC (U.K.), Koninklijke Philips N.V. (Netherlands), ZOLL Medical Corporation (U.S.), Cardiac Science Corporation (U.S.), Physio-Control, Inc. (U.S.), and Nihon Kohden Corporation (Japan)
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Implantable Cardioverter Defibrillators (ICDS)
5.1.2.1 Transvenous Implantable Cardioverter Defibrillators (T-ICDS)
5.1.2.1.1 Biventricular ICDS/Cardiac Resynchronization Therapy Defibrillators (CRT-DS)
5.1.2.1.2 Dual-Chamber ICDS
5.1.2.1.3 Single-Chamber ICDS
5.1.2.2 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
5.1.3 External Defibrillators
5.1.3.1 Automated External Defibrillators (AEDS)
5.1.3.1.1 Semi-Automated External Defibrillators
5.1.3.1.2 Fully Automated External Defibrillators
5.1.3.2 Manual External Defibrillators
5.1.3.3 Wearable Cardioverter Defibrillators (WCDS)
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 End User
5.2.1 Introduction
5.2.2 Hospitals, Clinics, & Cardiac Centers
5.2.3 Pre-Hospitals
5.2.4 Public Access Markets
5.2.5 Home Care
5.2.6 Alternate Care Markets
5.2.7 Y-o-Y Growth Analysis, By End User
5.2.8 Market Attractiveness Analysis, By End User
5.2.9 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By End User
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Medtronic PLC
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 St. Jude Medical, Inc.
8.3 Boston Scientific Corporation
8.4 Philips Healthcare (A Division of Koninklijke Philips N.V.)
8.5 Zoll Medical Corporation (A Subsidiary of Asahi Kasei Corporation)
8.6 Biotronik Se & Co.Kg
8.7 Physio-Control International, Inc.
8.8 Cardiac Science Corporation (A Portfolio Company of Aurora Capital Group)
8.9 Sorin Group (Now Livanova PLC)
8.10 Nihon Kohden Corporation
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020